Teva Pharmaceutical Industries Ltd Stock Rating Reiterated

Teva Pharmaceutical Industries Ltd has had its stock rating reiterated as ‘Overweight’ by JPMorgan ahead of the company’s Q2 earnings.

Recent Developments in the Pharmaceutical Industry

Johnson & Johnson has won an appeals court ruling against Teva and Viatris in a patent dispute over a neuro drug.

Alvotech Announcements

Alvotech, a global biotech company, has made significant announcements, including:

• The appointment of Linda Jónsdóttir as Chief Financial Officer
• The expansion of its capacity in assembly and packaging with the acquisition of Ivers-Lee in Switzerland

Impact on the Pharmaceutical Industry

These events are likely to have an impact on the pharmaceutical industry, but their direct effect on Teva’s stock price remains to be seen.